Cohance Lifesciences: Promoters' 57.49% Stake Encumbered

Cohance Lifesciences Limited has disclosed that its promoters, Berhyanda Limited and Jusmiral Holdings Limited, have encumbered a significant portion of their shareholding. CSC Global Capital Markets (Singapore) Pte Ltd, acting as agent and offshore security agent for lenders, has received the disclosure under SEBI SAST Regulations. This encumbrance affects 219,930,170 equity shares, representing 57.49% of the total share capital, due to term loan facilities availed by the promoters. The encumbrance, effective from June 16, 2026, includes restrictions on disposal and creation of further security.